← Back to all news
Product newsJune 29, 2023

Quantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis

Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is proud to unveil the latest addition to its offering: a service for DNA amplification for use in mRNA applications.

Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is proud to unveil the latest addition to its offering: a service for DNA amplification for use in mRNA applications. DNA is a critical starting material for mRNA production, and high-quality linear DNA templates are essential for efficient in vitro transcription.

With Nplify, Quantoom expands its N-Force toolbox to support partners from sequence design through RNA production, offering a high-quality linear DNA service tailored for mRNA synthesis workflows.